GE HealthCare Technologies Inc. $GEHC is Trian Fund Management L.P.’s 6th Largest Position

Trian Fund Management L.P. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 76,194.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,085,344 shares of the company’s stock after buying an additional 3,081,300 shares during the quarter. GE HealthCare Technologies comprises about 4.7% of Trian Fund Management L.P.’s holdings, making the stock its 6th largest position. Trian Fund Management L.P.’s holdings in GE HealthCare Technologies were worth $197,493,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after acquiring an additional 267,058 shares during the last quarter. Auto Owners Insurance Co lifted its holdings in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after purchasing an additional 33,629,559 shares during the last quarter. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 13.4% during the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares during the last quarter. Capital Research Global Investors boosted its position in GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after purchasing an additional 389,796 shares during the period. Finally, State Street Corp boosted its position in GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after purchasing an additional 401,932 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on GEHC. BMO Capital Markets started coverage on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price target on the stock. HSBC cut their price objective on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. BTIG Research reiterated a “buy” rating and issued a $79.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday. The Goldman Sachs Group reissued a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Finally, Piper Sandler restated a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. Ten research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $77.73.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $74.82 on Friday. The company has a 50 day moving average of $66.61 and a 200 day moving average of $69.60. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. The stock has a market cap of $33.80 billion, a P/E ratio of 17.16, a P/E/G ratio of 2.16 and a beta of 0.69. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The business had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same period in the prior year, the company posted $1.06 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.21%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.